189 related articles for article (PubMed ID: 38547092)
21. Multicenter validation of the liver graft assessment following transplantation (L-GrAFT) score for assessment of early allograft dysfunction.
Agopian VG; Markovic D; Klintmalm GB; Saracino G; Chapman WC; Vachharajani N; Florman SS; Tabrizian P; Haydel B; Nasralla D; Friend PJ; Boteon YL; Ploeg R; Harlander-Locke MP; Xia V; DiNorcia J; Kaldas FM; Yersiz H; Farmer DG; Busuttil RW
J Hepatol; 2021 Apr; 74(4):881-892. PubMed ID: 32976864
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model.
Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW
JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831
[TBL] [Abstract][Full Text] [Related]
23. Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury.
Nakamura K; Kageyama S; Kaldas FM; Hirao H; Ito T; Kadono K; Dery KJ; Kojima H; Gjertson DW; Sosa RA; Kujawski M; Busuttil RW; Reed EF; Kupiec-Weglinski JW
J Clin Invest; 2020 May; 130(5):2689-2704. PubMed ID: 32027621
[TBL] [Abstract][Full Text] [Related]
24. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
Deschênes M; Belle SH; Krom RA; Zetterman RK; Lake JR
Transplantation; 1998 Aug; 66(3):302-10. PubMed ID: 9721797
[TBL] [Abstract][Full Text] [Related]
25. Postoperative fibrinolytic resistance is associated with early allograft dysfunction in liver transplantation: A prospective observational study.
Moore HB; Saben J; Rodriguez I; Bababekov YJ; Pomposelli JJ; Yoeli D; Ferrell T; Adams MA; Pshak TJ; Kaplan B; Pomfret EA; Nydam TL
Liver Transpl; 2023 Jul; 29(7):724-734. PubMed ID: 36749288
[TBL] [Abstract][Full Text] [Related]
26. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients.
Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G
Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732
[TBL] [Abstract][Full Text] [Related]
27. Decreasing Significance of Early Allograft Dysfunction with Rising Use of Nonconventional Donors.
Ohara S; Macdonough E; Egbert L; Brooks A; Lizaola-Mayo B; Mathur AK; Aqel B; Reddy KS; Jadlowiec CC
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744084
[TBL] [Abstract][Full Text] [Related]
28. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation.
Hoyer DP; Paul A; Gallinat A; Molmenti EP; Reinhardt R; Minor T; Saner FH; Canbay A; Treckmann JW; Sotiropoulos GC; Mathé Z
Liver Int; 2015 Jan; 35(1):156-63. PubMed ID: 24351095
[TBL] [Abstract][Full Text] [Related]
29. Impact of Rifaximin Therapy on Ischemia/Reperfusion Injury in Liver Transplantation: A Propensity Score-Matched Analysis.
Ito T; Nakamura K; Kageyama S; Korayem IM; Hirao H; Kadono K; Aziz J; Younan S; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
Liver Transpl; 2019 Dec; 25(12):1778-1789. PubMed ID: 31509643
[TBL] [Abstract][Full Text] [Related]
30. The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation.
Selten JW; Verhoeven CJ; Heedfeld V; Roest HP; de Jonge J; Pirenne J; van Pelt J; Ijzermans JNM; Monbaliu D; van der Laan LJW
Liver Transpl; 2017 Jul; 23(7):946-956. PubMed ID: 28388830
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic pretreatment alleviates liver transplant damage in mice and humans.
Nakamura K; Kageyama S; Ito T; Hirao H; Kadono K; Aziz A; Dery KJ; Everly MJ; Taura K; Uemoto S; Farmer DG; Kaldas FM; Busuttil RW; Kupiec-Weglinski JW
J Clin Invest; 2019 Jul; 129(8):3420-3434. PubMed ID: 31329160
[TBL] [Abstract][Full Text] [Related]
32. Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation.
Ni C; Masters J; Zhu L; Yu W; Jiao Y; Yang Y; Cui C; Yin S; Yang L; Qi B; Ma D
Trials; 2020 Jun; 21(1):582. PubMed ID: 32591004
[TBL] [Abstract][Full Text] [Related]
33. Prolyl Hydroxylase Inhibition Mitigates Allograft Injury During Liver Transplantation.
Harnoss JM; Cai J; Hinterkopf S; Radhakrishnan P; Schmitt A; Dupovac M; Nees LK; Strowitzki MJ; Taylor CT; Schneider M
Transplantation; 2022 Oct; 106(10):e430-e440. PubMed ID: 35849574
[TBL] [Abstract][Full Text] [Related]
34. Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation.
Friedman BH; Wolf JH; Wang L; Putt ME; Shaked A; Christie JD; Hancock WW; Olthoff KM
Liver Transpl; 2012 Feb; 18(2):166-76. PubMed ID: 22006860
[TBL] [Abstract][Full Text] [Related]
35. The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function.
Fukazawa K; Pretto EA
J Hepatobiliary Pancreat Sci; 2011 May; 18(3):406-13. PubMed ID: 21104279
[TBL] [Abstract][Full Text] [Related]
36. Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
Yang L; Xin EY; Liao B; Lai LJ; Han M; Wang XP; Ju WQ; Wang DP; Guo ZY; He XS
Transplant Proc; 2017; 49(6):1357-1363. PubMed ID: 28736007
[TBL] [Abstract][Full Text] [Related]
37. Risk factors of early liver dysfunction after liver transplantation using grafts from donation after citizen death donors.
He YB; Sun JS; Wang ZP; Yao G; Bai L; Li T; Zhao JM
Transpl Immunol; 2022 Apr; 71():101525. PubMed ID: 34990790
[TBL] [Abstract][Full Text] [Related]
38. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study.
Lominchar PL; Orue-Echebarria MI; Martín L; Lisbona CJ; Salcedo MM; Olmedilla L; Sharma H; Asencio JM; López-Baena JÁ
World J Hepatol; 2019 Sep; 11(9):689-700. PubMed ID: 31598193
[TBL] [Abstract][Full Text] [Related]
39. Peri-transplant lactate levels and delayed lactate clearance as predictive factors for poor outcomes after liver transplantation: A propensity score-matched study.
Takahashi K; Jafri SR; Safwan M; Abouljoud MS; Nagai S
Clin Transplant; 2019 Jul; 33(7):e13613. PubMed ID: 31119814
[TBL] [Abstract][Full Text] [Related]
40. Glycocalyx Damage Within Human Liver Grafts Correlates With Graft Injury and Postoperative Graft Function After Orthotopic Liver Transplantation.
Schiefer J; Faybik P; Koch S; Tudor B; Kollmann D; Kuessel L; Krenn CG; Berlakovich G; Baron DM; Baron-Stefaniak J
Transplantation; 2020 Jan; 104(1):72-78. PubMed ID: 31283668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
